FDA approves Promacta sNDA

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) jumped $2.40 (14%) to $19.07 on Monday after FDA approved an sNDA from partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) for Promacta eltrombopag to treat throm...